Dicerna - OXLUMO™ - Ownership and Business Overview

Life ScienceCompany

Dicerna - OXLUMO™ Ownership

Who owns Dicerna - OXLUMO™?

Dicerna - OXLUMO™ is owned by Royalty Pharma. It was acquired on April 8, 2021.

Dicerna - OXLUMO™ Business Overview

Where is Dicerna - OXLUMO™ headquartered?

Dicerna - OXLUMO™ is headquartered in Lexington, Massachusetts.

What sector is Dicerna - OXLUMO™ in?

Dicerna - OXLUMO™ is a life science company.

Life Science M&A Summary in 2021

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021. The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was acquired by Thermo Fisher Scientific for $17.4B.

Join Mergr to view all 387 acquisitions of life science companies in 2021, including 43 acquisitions by private equity firms, and 344 by strategics.

Dicerna - OXLUMO™ (lumasiran)

Lexington, Massachusetts
United States,

Dicerna's OXLUMO has been approved by the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) for the treatment of primary hyperoxaluria (PH) type 1.


 Subscribe to unlock this and 201,882
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.